Previous close | 14.58 |
Open | 14.63 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 14.28 - 14.63 |
52-week range | 7.83 - 24.01 |
Volume | |
Avg. volume | 457 |
Market cap | 1.999M |
Beta (5Y monthly) | 1.08 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Pharming Group (PHAR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Key Insights Institutions' substantial holdings in UroGen Pharma implies that they have significant influence over the...
UroGen Pharma ( NASDAQ:URGN ) Full Year 2023 Results Key Financial Results Revenue: US$82.7m (up 28% from FY 2022). Net...